hims semaglutide results Ozempic® Hims expansion may not come

Phase 2 trial: up to 24.2% weight loss at 48 weeks

The metabolic syndrome constellation (E88.81) abdominal obesity, hypertriglyceridemia, low HDL, hypertension, and elevated fasting glucose frequently co-occurs with obesity and compounds cardiovascular risk

At Set Point Medical Weight Loss Clinic, we understand that successful weight management is about more than just medicationits about creating sustainable lifestyle changes that support your health and long-term goals

This dual action provides several benefits: Enhanced insulin secretion when blood sugar is elevated Suppressed glucagon release to reduce liver glucose production Slowed gastric emptying leading to increased satiety Improved fat metabolism through GIP receptor activation Better insulin sensitivity in peripheral tissues The unique aspect of tirzepatide is its imbalanced design it has a stronger affinity for GIP receptors than GLP-1 receptors, which may contribute to its enhanced efficacy while potentially minimizing certain side effects

J Neurol Sci 168 : 112115 (1999)

Effekten af GLP-1 gr hnd i hnd med kroppens vrige optagelse af mad